Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

People with diabetes are at risk of chronic complications and novel biomarkers, such as Advanced glycation end-products (AGEs) may help stratify this risk. We assessed whether plasma low-molecular weight AGEs, also known as LMW-fluorophores (LMW-F), are associated with risk factors, predict complica...

Full description

Saved in:
Bibliographic Details
Main Authors: Januszewski, Andrzej S., Chen, David, Scott, Russell S., O'Connell, Rachel L., Aryal, Nanda R., Sullivan, David R., Watts, Gerald F., Taskinen, Marja-Riitta, Barter, Philip J., Best, James D., Simes, John R., Keech, Anthony C., Jenkins, Alicia J.
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2021
Subjects:
Science::Medicine
Diabetes
Endocrinology
Online Access:https://hdl.handle.net/10356/153807
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English

Internet

https://hdl.handle.net/10356/153807

Similar Items